Active ingredientRazoxaneCat. No. P-R021-001CAS 21416-67-1Family · Pharmaceutical analytical standards
Razoxane
An antitumour agent of the bisdioxopiperazine family, described in 1969 by researchers at the Imperial Cancer Research Fund in London (hence the code ICRF-159): it inhibits topoisomerase II and was studied against tumours, metastases and psoriasis. This family brings together the active ingredient and other impurities.
Did you know?Its dextrorotatory enantiomer, dexrazoxane (ICRF-187), became a medicine in its own right: it protects the heart from the damage caused by anthracyclines used in chemotherapy.
Go to the active ingredient →Active ingredientRazoxaneCat. No. P-R021-001CAS 21416-67-1
Impurity(R)-RazoxaneCat. No. P-R021-002CAS 24613-06-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.